Researcher
Ann Smeets
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 5 of 5
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From6 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From1 Oct 2021 → TodayFunding: BOF - projects
- Connecting Single-cell Immune Profiling in Peripheral Blood with Intratumoral T Cell Expansion in Breast Cancer Upon Checkpoint ImmunotherapyFrom24 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancerFrom1 Oct 2016 → 15 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 118
- Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study.(2022)
Authors: Gwen Schroyen, Charlotte Sleurs, Koenraad Van Laere, Ann Smeets, Sabine Deprez
Pages: 61 - 68 - Biopsychosocial risk factors for pain and pain-related disability 1 year after surgery for breast cancer(2022)
Authors: Lore Dams, Nele Devoogdt, Ann Smeets, Tessa De Vrieze, An De Groef
Pages: 4465 - 4475Number of pages: 11 - Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review.(2022)
Authors: Gwen Schroyen, Julie Vissers, Ann Smeets, Céline Gillebert, Jurgen Lemiere, Sabine Deprez, Charlotte Sleurs
Pages: 101297 - Rare germline copy number variants (CNVs) and breast cancer risk(2022)
Authors: Diether Lambrechts, Ann Smeets
Number of pages: 15 - Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancer(2021)
Authors: Hanne Vos, Ann Smeets, Giuseppe Floris, Ines Nevelsteen
- Towards a better understanding of pain after surgery for breast cancer: a biopsychosocial perspective(2021)
Authors: Lore Dams, Nele Devoogdt, An De Groef, Ann Smeets
- Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Authors: Hanne Vos, Kathleen Lambein, François Richard, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Giuseppe Floris, Christine Desmedt, Ann Smeets
Number of pages: 5 - Mendelian randomisation study of smoking exposure in relation to breast cancer risk(2021)
Authors: Sileny Han, Diether Lambrechts, Ann Smeets
Pages: 1135 - 1145Number of pages: 11 - Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer(2021)
Authors: Gwen Schroyen, Jeroen Blommaert, Charlotte Sleurs, Mathieu Vandenbulcke, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koenraad Van Laere, Stefan Sunaert, et al.
Number of pages: 15 - Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3(2021)
Authors: Lore De Cock, Kevin Punie, Ann Smeets, Caroline Weltens, Patrick Neven, Jaak Billen, Annouschka Laenen, Hans Wildiers
Pages: 1 - 9Number of pages: 9